sum: In the UK Recovery trial, and in WHO Solidarity trials, HCQ is used in a non-therapeutic, toxic and potentially lethal dose. HCQ is furthermore being given, in clinical trials, too late in the disease course to determine its value against SARS-CoV-2.

Tekið úr bloggi: 

slóð 

@Anonymous above my post, these trials (Recovery and Solidarity and REMAP) were designed to kill patients to discredit Hydroxychloroquine. Some studies using reasonable doses show a very good reduction in mortality, even for vulnerable patients.

3.10.2020 | 21:32

To sum up:

1. 1.  In the UK Recovery trial, and in WHO Solidarity trials, HCQ is used in a non-therapeutic, toxic and potentially lethal dose.
2. 2.  HCQ is furthermore being given, in clinical trials, too late in the disease course to determine its value against SARS-CoV-2.
3. 3.  Collection of limited safety data in the Solidarity trials serves to protect trial investigators and sponsors from disclosures of expected adverse drug effects, including death.
4. 4.  It appears that WHO has tried to hide information on the hydroxychloroquine doses used in its Solidarity trial.  Fortunately, the information is discoverable from registries of its national trials.
5. 5.  The conclusions to be drawn are frightening:

1.  a)  WHO and other national health agencies, universities and charities have conducted large clinical trials that were designed so hydroxychloroquine would fail to show benefit in the treatment of Covid-19, perhaps to advantage much more expensive competitors and vaccines in development, which have been heavily supported by Solidarity and Recovery trial sponsors and WHO sponsors.
2.    b)  In so doing, these agencies and charities have de facto conspired to increase the number of deaths in these trials.
3.    c)   In so doing, they have conspired to deprive billions of people from potentially benefiting from a safe and inexpensive drug, when used properly, during a major pandemic.  This might contribute to prolongation of the pandemic, massive economic losses and many increased cases and deaths. Update June 18: I sent a tweet to WHO Director General Tedros informing him of these findings 3 days ago.  I also emailed WHO's Dr. Restrepo, inquiring about the doses used in the Solidarity trial.  I am very pleased to report thatWHO stopped this deadly trial yesterday, with no fanfare.  WHO claimed the decision was made on the basis of the Recovery trial result and a Cochrane review, as well as WHO data.  One wonders if the DSMB was bypassed again, as occurred on May 25 when WHO halted its HCQ arm for the first time. I had pointed out that if trial investigators had not disclosed to subjects the known risks associated with the high HCQ doses used, the investigators and WHO would be liable for damages.  I like to think my investigation has helped save some lives.

Posted by Meryl Nass, M.D. at 9:17 AM 

000

slóð

Hydroxychloroquine, drepur vírusinn, ef það er gefið strax, en ef vírusinn fær í friði að skaða líffæri, þá virkar þetta frábæra lyf síður. Bakteríudrepandi lyf virka þá hugsanlega betur. Bakteríulyf í dýrafóðri, gera virkni þeirra minni í mannfólkinu.

Jónas Gunnlaugsson | 5. september 2020

000

Egilsstaðir, 05.10.2020   Jónas Gunnlaugsson